Abstract
Tumor metastasis is a main contributor to death in cancer patients. In the last years, a new class of molecules that reduces the metastatic propensity has been identified: metastasis suppressors. These proteins regulate multiple steps in the metastatic cascade, including cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. As a consequence, they are very important therapeutic targets. This review discusses our current understanding of metastasis suppressors and how this knowledge might be useful to improve the treatment of cancer patients.
Keywords: Metastasis suppressor genes, metastatic cascade, suppressor-based therapies, cancer cell types, colonize ectopic tissue, metastatic process, Paget hypothesized, Innumerable oncogenes, amino acids, human genome, oral squamous cells, metastatic melanoma, Simpson-Golabi-Behmel syndrome (SGBS), micrometastatic tumor cells
Current Pharmaceutical Biotechnology
Title: Metastasis Suppressors: Basic and Translational Advances
Volume: 12 Issue: 11
Author(s): C. Buchanan, M. A. Lago Huvelle and M. G. Peters
Affiliation:
Keywords: Metastasis suppressor genes, metastatic cascade, suppressor-based therapies, cancer cell types, colonize ectopic tissue, metastatic process, Paget hypothesized, Innumerable oncogenes, amino acids, human genome, oral squamous cells, metastatic melanoma, Simpson-Golabi-Behmel syndrome (SGBS), micrometastatic tumor cells
Abstract: Tumor metastasis is a main contributor to death in cancer patients. In the last years, a new class of molecules that reduces the metastatic propensity has been identified: metastasis suppressors. These proteins regulate multiple steps in the metastatic cascade, including cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. As a consequence, they are very important therapeutic targets. This review discusses our current understanding of metastasis suppressors and how this knowledge might be useful to improve the treatment of cancer patients.
Export Options
About this article
Cite this article as:
Buchanan C., A. Lago Huvelle M. and G. Peters M., Metastasis Suppressors: Basic and Translational Advances, Current Pharmaceutical Biotechnology 2011; 12 (11) . https://dx.doi.org/10.2174/138920111798376914
DOI https://dx.doi.org/10.2174/138920111798376914 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Signaling Pathways Underpinning the Manifestations of Ionizing Radiation-Induced Bystander Effects
Current Molecular Pharmacology Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis
Current Cancer Drug Targets New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Large-Scale and Facile Synthesis of Biocompatible Yb-Based Nanoparticles as a Contrast Agent for In Vivo X-Ray Computed Tomography Imaging
Current Topics in Medicinal Chemistry Radioimmunotherapy of Metastatic Prostate Cancer with <sup>177</sup>Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
Current Radiopharmaceuticals Role of Biotransformation in Conceptal Toxicity of Drugs and Other Chemicals
Current Pharmaceutical Design MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer
Current Pharmaceutical Design Review on Documented Medicinal Plants used for the Treatment of Cancer
Current Traditional Medicine Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation
Current Drug Targets An Overview of Targeting Legumain for Inhibiting Cancers
Current Pharmaceutical Design Transition Metal-Based Prodrugs for Anticancer Drug Delivery
Current Medicinal Chemistry EGFR(s) in Aging and Carcinogenesis of the Gastrointestinal Tract
Current Protein & Peptide Science Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series
Current Drug Therapy Dual Acting Anti-Inflammatory Drugs
Current Topics in Medicinal Chemistry Nutraceutical: A Drug, Dietary Supplement and Food Ingredient
Current Pharmacogenomics and Personalized Medicine Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells
Current Cancer Drug Targets SELDI Protein Chip Technology for the Detection of Serum Biomarkers for Liver Disease
Protein & Peptide Letters Combined Cancer Therapy with Non-Conventional Drugs: All Roads Lead to AMPK
Mini-Reviews in Medicinal Chemistry Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets